The CDC and FDA reported last Friday that two samples collected by FDA tested positive for Clostridium botulinum type A.

One is a ByHeart powdered infant formula closed product sample that matches a clinical isolate from an infant included in this outbreak according to whole genome sequencing analysis (WGS). 

The second whole milk powder sample was

Today, January 23, 2026, the CDC and FDA reported that two samples collected by FDA tested positive for Clostridium botulinum type A: 

One is a ByHeart powdered infant formula closed product sample that matches a clinical isolate from an infant included in this outbreak according to whole genome sequencing analysis (WGS). 

The second whole milk powder

The FDA and CDC, in collaboration with the California Department of Public Health (CDPH), Infant Botulism Treatment and Prevention Program (IBTPP), and other state and local partners, continue to investigate a multistate outbreak of infant botulism. Epidemiologic and laboratory analyses indicate that ByHeart Whole Nutrition infant formula is the source of this multistate outbreak of

BEFORE THE UNITED STATES 

JUDICIAL PANEL ON MULTIDISTRICT LITIGATION 

 IN RE BYHEART INFANT BOTULISM LITIGATION   MDL DOCKET NO.               

PLAINTIFFS’ MOTION TO TRANSFER AND CENTRALIZE RELATED ACTIONS TO THE SOUTHERN DISTRICT OF NEW YORK PURSUANT TO 28 U.S.C. § 1407

Pursuant to 28 U.S.C. § 1407 and Rule 6.2 of the Rules of